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BACKGROUND: In vivo mouse models have been developed to study the physiology of normal and pathologic 
endometrium. Although angiogenesis is known to play an important role in endometrial physiology and 
pathology, the origin of neovasculature in xenografts remains controversial. The aim of this study was to assess 
the origin of the neovasculature of endometrial grafts in different mouse models. 
METHODS: Human proliferative endometrium (n = 19 women) was grafted s.c. in two immunodeficient mouse 
strains: nude (n = 8) and severely compromised immunodeficient (SCID; n = 20). Mice were also treated with 
estradiol, progesterone or levonorgestrel. Fluorescence in-situ hybridization using a centromeric human 
chromosome X probe, immunohistochemistry (von Willebrand factor and collagen IV) and lectin perfusion were 
performed to identify the origin of the vessels. 
RESULTS: More than 90% of vessels within xenografts were of human origin 4 weeks after implantation. Some 
vessels (9.67 ± 2.01%) were successively stained by human or mouse specific markers, suggesting the presence 
of chimeric vessels exhibiting a succession of human and murine portions. No difference in staining was 
observed between the two strains of mouse or different hormone treatments. Furthermore, erythrocytes were 
found inside human vessels, confirming their functionality. 
CONCLUSION: This article shows that human endometrial grafts retain their own vessels, which connect to 
the murine vasculature coming from the host tissue and become functional. 
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Introduction 
Angiogenesis is the process by which new microvessels develop from existing blood vessels. Angiogenesis 
occurs by four different mechanisms that are sprouting, intussusception, vessel elongation and incorporation of 
circulating endothelial progenitor cells (EPCs) into growing vessels (Asahara et al., 1997; Risau, 1997). 
In the healthy human adult, angiogenesis is rare except in the female reproductive system where angiogenesis 
occurs in the ovarian follicle, corpus luteum and uterine endometrium (Gordon et al., 1995; Fraser and Lunn, 
2000; Jaffe, 2000). These tissues undergo cyclic changes to provide the nutrients and hormone precursors 
essential to the establishment and maintenance of pregnancy. In the endometrium, angiogenesis plays a key role 
in shedding and regrowth during the menstrual cycle (Abulafia and  Sherer, 1999; Gargett and  Rogers, 2001; 
Smith, 2001; Girling and Rogers, 2005). Abnormal angiogenesis may contribute to excessive bleeding in women 
with heavy menstruation, endometriosis, breakthrough bleeding and infertility (Donnez et al., 1998; Krikun et 
al., 2004; Mints et al., 2005, 2007; Becker and DAmato, 2007; Saito et al., 2007; Stephanie et al., 2007). 
Angiogenesis is a crucial condition for the development and maintenance of endometriotic lesions: this role of 
angiogenesis has been recently demonstrated by Nap et al. (2004) using anti-angiogenic therapy in endometriosis 
induced in a mouse model. 
A large variety of in vivo models using rodents have been developed to study the physiology of normal and 
pathologic endometrium. These models use the transplantation of autologous or heterologous endometrial 
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cells/tissues or endometriotic tissues (Story and Kennedy, 2004; Matsuura-Sawada et al., 2005; Grummer, 2006; 
Masuda et al., 2007). Immunocompromised animals do not possess the ability to reject foreign tissue and 
therefore appear as ideal candidates for such studies. According to the strain of mouse used to implant human 
endometrium s.c, the graft exhibits different morphological features. In nude mice, various degrees of fibrosis 
develop around the endometrial graft. On the contrary, human endometrial grafts in severely compromised 
immunodeficient (SCID) mice retain their normal histological features with no fibrotic reaction (Alvarez 
Gonzalez et al., 2008). The main difference between the two strains of mice is that nude mice lack a thymus and 
cannot regenerate mature T lymphocytes whereas SCID mice lack both T and B lymphocytes. Differences in the 
fibrotic reaction between the two types of immunodeficient mice could modify angiogenesis in and around the 
endometrial graft, justifying investigation of graft vascularization in both strains. 
In a previous study, we evaluated the effects of levonorgestrel (LNG) on human endometrium implanted in 
SCID mice (Alvarez Gonzalez et al., 2008). LNG is considered as an efficient contraceptive delivered locally by 
an intrauterine device. LNG is known to alter the morphology and function of endometrium (Critchley et al., 
1998) as well as the endometrial vasculature by increasing blood vessel number, size and density and decreasing 
the pericyte coverage (Stephanie et al., 2007), altogether contributing to vascular fragility and breakthrough 
bleeding (Hickey et al., 2000; Rogers et al., 2000; Jondet et al., 2005). We demonstrated that human endometrial 
transplants reproduced similar histological characteristics and hormonal response when compared with eutopic 
human endometrium (Alvarez Gonzalez et al., 2008). 
Although angiogenesis is known to play an important role in endometrial physiology and pathology, the origin of 
neovasculature in xenografts remains controversial (Grummer et al., 2001; Bruner-Tran et al., 2002; Eggermont 
et al., 2005; Masuda et al., 2007). 
In the present study, two immunodeficient mouse models were used to identify the origin of the neovasculature 
in grafts. Fluorescence in-situ hybridization (FISH), immunohistochemistry and lectin perfusion were performed 
to compare vessels in nude and SCID mice. As steroid hormones influence endometrial angiogenesis, 
progesterone and LNG were administered to the experimental animals. 
Materials and Methods 
Collection of human endometrium 
The use of human tissue was approved by the Ethical Committee of the University of Liege, and an informed 
consent has been signed by all the women involved in the present study. Proliferative endometrium (5-9 cycle 
days) was obtained from 19 women of reproductive age (aged 31-38 years) without endometriosis undergoing 
surgery for benign purposes (uterine myoma). They had regular menstrual cycles and did not receive any 
hormonal treatment for at least 3 months before surgery. 
Each endometrial biopsy was collected with a Cornier Pipelle suction curette (C.C.D. International, Paris, 
France), placed in sterile phosphate-buffered saline (PBS) solution, pH 7.3, and immediately transported to the 
laboratory. Part of the endometrial biopsy was fixed in 4% buffered formaldehyde, dehydrated and embedded in 
paraffin. Sections (5 µm-thick) were stained with haematoxylin-eosin for histological confirmation of the 
menstrual phase (Noyes et al., 1950). 
Animals 
Experiments were approved by the Liege University Animal Ethical Committee. 
Female SCID/SCID CB17 and Swiss nu/nu mice (8-10 weeks) were obtained from Charles River Laboratories 
(Brussels, Belgium) and housed under a barrier husbandry in a controlled pathogen free environment with a 12 h 
light/12 h dark cycle. All housing materials, food and water were autoclaved before use. Mice were fed ad 
libitum on laboratory chow and water. 
Transplantation into mice and tissue processing 
All surgical procedures were conducted in a sterile laminar flow hood under parenteral anaesthesia with an 
injection of a solution containing 10 mg/kg of Xylalin® and 80 mg/kg body weight of Ketamine 1000 Ceva® 
(both from Ceva Sante Animale, Libourne, France). 
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Eight nude mice were implanted s.c. in the neck region with a pellet of 17β-estradiol (E2). 
SCID mice were s.c. implanted either with E2 alone (n = 8), with E2+ progesterone (n = 4) or with E2+ LNG (n = 
8). E2 and progesterone pellets were from Innovative Research of America, Sarasota, USA and contained, 
respectively, 1.72 and 25 mg of steroid, which were released at constant rate for 60 days. LNG was delivered by 
two poly-dimethylsiloxane implants inserted s.c. Each implant released 10 µg of LNG per day. 
At least 2 days after insertion of the hormonal pellet, 10 fragments of fresh human proliferative endometrium (1-
2 mm3) per animal were grafted s.c. in the dorsal region of animals of both strains. Mice were sacrificed 3 or 4 
weeks after endometrial transplantation. Depending on the size of the biopsy sample, 1 to 4 mice were grafted 
simultaneously. 
The dorsal skin was removed and the adhering grafts were recovered and fixed in 4% buffered formalin and 
embedded in paraffin. Sections (5 µm-thick) were stained with haematoxylin-eosin for histological analysis or 
used for FISH and immunohistochemistry. Some grafts were fixed for 4 h at 4°C in 4% paraformaldehyde, 
cryopreserved in 30% sucrose/PBS overnight at 4°C and stored at -80°C until used for immunohistochemistry. 
Fluorescence in-situ hybridization 
Paraffin embedded sections were dewaxed in xylene and dehydrated in 100% ethanol. Sections were transferred 
for 20 min to 0.2 N HCl, washed in double distilled water (DDW) and in 2 x saline sodium citrate (2 x SSC, 0.3 
M NaCl and 30 mM sodium citrate, pH 7.0, NV Invitrogen SA, Merelbeke, Belgium) for 3 min each and 
transferred to a pre-treatment solution (I N NaSCN, 71938, Fluka, Sigma-Aldrich NV/SA, Bornem, Belgium) at 
80°C for 15 min. Sections were then washed in DDW for 1 min followed by 2 x 5 min in 2 x SSC Sections were 
incubated with Proteinase K (031 15879001, Roche SA, Brussels, Belgium; 0.25 mg/ml) at 37°C for 5 min, then 
washed in 2 x SSC for 2 x 5 min and fixed in 4% formaldehyde before being dehydrated through a 50 ml ethanol 
series: 70, 85 and 100% for 2 min each. Sections were denatured at 72°C for 5 min in 70% formamide/2 x SSC 
(pH 7) and then dehydrated in ethanol series as above. 
The centromeric human chromosome X probe (CEP X Spectrum-Green, 32-132023, Vysis, Abbott SA/NV, 
Ottignies/Louvain-La-Neuve, Belgium) was denatured at 72°C for 5 min and then incubated at 37°C for 30-60 
min. 
Probe was applied to the section and then allowed to hybridize at 37°C overnight. Slides were washed in 2 x 
SSC/0.3% Tween 20 at 72°C for 2 min and then transferred to 2 x SSC at room temperature for 2 min. Ethanol 
series dehydration was performed as above and the slides were air dried in darkness. The slides were mounted 
and counterstained with Vectashield medium containing propidium iodide (H-1300, Vector Laboratories, 
Laboconsult SPRL, Brussels, Belgium). 
Immunohistochemistry 
Vascular studies were performed on 50 µm-thick cryosections. The human endothelial cells were stained using a 
rabbit polyclonal anti-human von Willebrand factor (vWF, A082, Dako, Glostrup, Denmark, dilution/200). All 
blood vessels were visualized using a vascular basement membrane antibody against human and mouse collagen 
IV (SIF 100, guinea pig polyclonal antibody produced in our laboratory, dilution 1/1000) (Van Cauwenberge et 
al., 1983). 
Human stromal cells were stained using mouse monoclonal anti-CD 10 antibody considered as a reliable and 
sensitive immunohistochemical marker for normal and neoplastic endometrial stroma (McCluggage et al., 2001) 
(NCL-CDIO-270, Novocastra Laboratories Ltd, UK; dilution/50) on 5 µm-thick paraffin sections. To unmask 
antigens, slides were autoclaved for 11 min at 126°C and 1.4 bar in EDTA buffer. Endogenous peroxides were 
blocked by 3% H2O2 for 20 min and non-specific binding was prevented by incubation in PBS containing 10% 
bovine serum albumin (Fraction V, Acros Organics, NJ, USA) for 1h. Sections were incubated overnight at 4°C 
with the primary antibody. 
Slides were then incubated 1h at room temperature with an appropriate secondary antibody: FITC-conjugated 
mouse anti-guinea pig (F5642, Sigma-Aldrich NV/SA, dilution 1/100), biotinylated goat anti-rabbit (E432, 
Dako, dilution 1/400) followed by incubation with Cy3-conjugated streptavidin (S6402, Sigma-Aldrich NV/SA, 
dilution 1: 1000) at room temperature for 1h, or biotinylated goat anti-mouse (E433, Dako, dilution/400) 
followed by incubation with streptavidin/horse-radish peroxidase complex (P0397, Dako, dilution 1:500) at 
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room temperature for 30 min. Staining was performed with 3-3' diaminobenzidine hydrochloride (K3468, Dako) 
for 3 min. Slides were finally mounted with Vectashield Dapi (H-1200, Vector Laboratories) or counterstained 
with haematoxylin and mounted with Eukitt medium for light microscopy observation. Negative controls were 
performed both by omission of the primary antibody and by its replacement by an appropriate isotype control 
(mouse immunoglobulin (Ig)GI, X0931, or rabbit Ig fraction, X0936, Dako). 
Lectins 
Between 3 and 4 weeks after grafting, a mixture of FITC-conjugated lyco-persicon esculentum tomato lectin 
(LEA-FITC, FL1171, Vector Laboratories) and tetramethylrhodamine B isothiocyanate (TRITC)-conjugated 
helix pomatia agglutinin (HPA-TRITC, L1261, Sigma-Aldrich NV/SA) at a final concentration of 1 mg/ml was 
injected into the tail vein of 12 anesthetized mice (three per strain and per treatment). LEA-FITC binds to the 
luminal surface of endothelial cells of humans and mice (Kawashima et al., 1990; Zeng et al., 1998; Murphy et 
al., 1999; Pena et al., 2000; Debbage et al.,2001) whereas HPA-TRITC binds to vascular endothelial cells in 
most mammalian species except human (Galili et al., 988; Galili, 1989; Rydberg et al., 1999; Debbage et al., 
2001 ). Mice were sacrificed 3 min later and lesions were immediately recovered and fixed for 4 h at 4°C in 4% 
paraformaldehyde. Grafts were then cryopreserved in 30% sucrose/PBS overnight at 4°C and stored at -80°C. 
Cryosections were cut at 50 µm thick, dried on Superfrost Plus slides (Fisher Scientific, Tournai, Belgium) for at 
least 18 h, rinsed with PBS and mounted in Vectashield Dapi or Propidium iodide (Vector Laboratories). 
Analysis of endometrial vasculature 
For each graft, 50 µm sections were double stained for vWF and SIF 100. RGB pictures were collected from 
these double-stained sections as well as from the lectin sections. All these were converted to eight bit gray scale 
images (fluorescence intensity range: 0-255) and analysed using ImageJ software (http://rsb.info.nih.gov/ij/). 
Total area stained by each antibody or by the lectins was binarized using an appropriate threshold for 
distinguishing pixels of the vasculature (score 1) from those of the background (score 0). The area measured for 
vWF (human cells) was expressed as a percentage of area measured for SIF 100 (human and mouse cells). The 
area measured for HPA-TRITC (mouse) was expressed as a percentage of the area measured for LEA-FITC 
(human and mouse). As no difference in endometrial vasculature staining was observed between the two strains 
of mouse or treatments, values were grouped and expressed as mean + SD (n = 12). 
Results 
Fluorescence in-situ hybridization 
The origin of all components of the endometrial tissue developed after grafting was determined by FISH using a 
specific centromeric human chromosome X probe (Fig. 1). All glandular and stromal cells were FISH positive 
confirming their human origin (Fig. 1b). However, in the fibrotic area which developed around the endometrial 
tissue, the absence of FISH positive cells demonstrated that the fibroblasts were from murine origin. 
By FISH technique, vessels can be visualized solely by the presence of autofluorescent erythrocytes. We 
observed FISH-positive cells bordering the lumen of all vessels identified in the endometrial stroma. In contrast, 
in the surrounding fibromuscular tissue, no such labelling was observed (Fig. 2). The FISH-positive cells were 
probably endothelial cells and the presence of erythrocytes suggested that this human-derived vasculature was 
functional. 
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Figure I Two consecutive sections through a subcutaneous human endometrial graft in a mouse host (3-4 weeks 
after grafting) were stained either by immunohistochemistry using a mouse monoclonal anti-human CD 10 
antibody, which shows human stromal cells in brown (a) or by FISH using the centromeric human chromosome 
X probe (b). 
FISH labelling (green dots) is observed in endometrial glands (G) and stroma (S), but not in the fibrotic tissue 
(F) surrounding the endometrial lesions. The enlarged view in (b) corresponds to the area delineated in (a). 
Autofluorescent erythrocytes are easily visualized (large yellow bodies). Images are representative of n = 8 
mice. Scale bar = 50 µm (a) and 40 µm (b). 
 
 
 
Figure 2 FISH with centromeric human chromosome X probe in the human endometrial grafts in mice (green 
dots). 
No staining is observed in blood vessels located in the fibrotic tissue close to an endometrial gland (GE) of the 
graft (a). By contrast, positive staining is observed in the endometrial stroma and in vessels present in the 
stroma (arrows) (b). The vessels can be easily visualized by the presence of highly autofluorescent erythrocytes. 
Images are representative of n= 8 mice. L: lumen; GE: glandular epithelium; F: fibrosis; E: erythrocytes; S: 
stroma Scale bar = 16 µm. 
 
 
Immunohistochemistry 
The vasculature was visualized in 50 µm sections by double immunos-taining of the endothelial cells (vWF) and 
the vascular basement membrane (SIF100) (Fig. 3). vWF was specific for human endothelial cells since no 
vessels were stained in the mouse tissue (MT) surrounding the lesion (Fig. 3a). The majority of vessels in the 
endometrial stromal tissue of the grafts were double stained (Fig. 3a and c). Closer observation of the sections 
highlighted the absence of vWF labelling in portions of vessels otherwise labelled with SIF 100 in a small 
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proportion (9.67 + 2.01%; n = 12) of vessels, suggesting their chimeric character, with portions of human and 
mouse origin (Fig. 3b and d). 
 
Figure 3 Double-immunohistochemical staining of a 50 µm-thick section through a subcutaneous human 
endometrial graft in mice with (a and b) rabbit polyclonal anti-human von Willebrand factor (vWF—red), 
labelling human endothelial cells, and (c and d) guinea-pig polyclonal anti-human and anti-mouse collagen IV 
(SIF 100—green), labelling the vascular basement membrane. 
Details of areas delineated in (a) and (c) are enlarged in (b) and (d), respectively. There are no vWF-positive 
cells in MT surrounding the graft (a). Within the endometrial stroma, the absence of vWF labelling in portions of 
vessels otherwise labelled with SIF 100 suggests their chimeric character (b and d). Images are representative of 
n = 12 mice. Scale bar = 100 µm in a and c, and 25 µm in b and d. 
 
 
 
Lectins 
To confirm the presence of chimeric vessels, we analysed 50 µm-thick sections obtained after simultaneous in 
vivo perfusion with LEA-FITC, staining human and mouse endothelial cells in green, and HPA-TRITC, staining 
only mouse endothelial cells in red (Fig. 4). 
HPA-TRITC labelling was specifically observed in the MT surrounding the graft (data not shown). In the 
stroma, some vessels were stained by the two lectins. Closer observation revealed that these vessels  exhibited  
successive  portions that were  either of murine (labelled by HPA-TRITC and LEA-FITC) or human (labelled 
only by LEA-FITC) origin (Fig. 4d). The success of the perfusion with the two lectins further confirmed that 
these vessels were functional. 
No difference in vascularization was observed between mouse strain or hormonal treatments. In all groups, 
chimeric vessels were demonstrated in the endometrial stroma throughout the xenograft and not only at the edge 
next to the host MT (Fig. 4e). We never found chimeric vessels in the fibrotic tissue surrounding the lesions. The 
proportion of vessels from murine origin was estimated at 10.76 ± 1.93% (n = 12) thereby confirming the results 
obtained with the vWF/SIF 100 double labelling method (see above). The presence of erythrocytes in the 
vasculature enabled us to show that, as early as 3 weeks after the grafting procedure, human and murine blood 
vessels were connected and functional. 
Published in : Human Reproduction (2009) 
Status : Postprint (Author’s version) 
Figure 4 Semithick section (50 µm) through subcutaneous human endometrial grafts in mouse simultaneously 
perfused with the lectin helix pomatia agglutinin tetramethylrhodamine B isothiocyanate (HPA-TR.ITC) (a), 
staining mouse endothelial cells, and with the FITC-conjugated lycoper-sicon esculentum tomato lectin (LEA-
FITC) (b), staining both human and mouse endothelial cells. 
Single views in (a) and (b) are merged in (c) and (d), showing portions of vessels with different origins. Details 
of areas delineated in merged picture (c) are enlarged in (d). The whole section was reconstructed in (e) and (f) 
to show the limits of the graft either by HPA-TRJTC (e) or LEA-FITC (f). Small murine vessels (in red) are 
observed throughout the graft (e), i.e. at the edge and in the middle. The views in (a) and (b) correspond to the 
area delineated in (e) and (f). Images are representative of n = 12 mice. Scale bar = 100 µm in a, b, c, and 25 
µm in d. 
 
 
Discussion 
This manuscript describes the presence of chimeric vessels (i.e. vessels exhibiting a succession of murine and 
human portions) throughout human endometrial expiants grafted in different mouse models. 
Angiogenesis of human endometrial grafts is a crucial step for their survival and growth (Nap et al., 2004). In 
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mouse models used to study endometrial pathologies, human endometrium is most often transplanted into either 
nude or SCID mice. The new vessels could then arise from human or mouse pre-existing vessels. Several authors 
evaluated angiogenesis in endometrial tissues transplanted in mice and showed that endometrial lesions derive 
their blood supply from the surrounding vascular network (Grümmer et al., 2001; Bruner-Tran et al., 2002). 
Nisolle et al., (2000) evaluated angiogenesis with immunostaining using polyclonal anti-vascular endothelial 
growth factor (VEGF) antibody and observed the presence of some capillaries between the graft and the mouse 
peritoneal wall with VEGF-positive endothelial cells. However, these authors did not propose the presence of 
chimeric vessels. Grümmer et al., stained vessels of human origin with anti-vWF antibody and endothelia of 
mouse vessels with a rat anti-mouse pan-endothelial cell antibody. They observed only vessels from mouse 
origin in endometrial lesions (Grummer et a/., 2001).  By staining endothelial cells with antibodies raised against 
human or mouse CD-31, Masuda et al. (Masuda et a/., 2007) demonstrated human-mouse chimeric vessels in 
reconstructed endometrium following transplantation of dispersed endometrial cells beneath kidney capsule of 
ovariectomized NOD/SCID/γcnull (NOG) mice. Masuda et al. suggested that the lack of vessels of human 
endometrial graft origin in SCID and nude mice in previous studies (Grümmer et a/., 2001; Bruner-Tran et al., 
2002; Hull et al., 2003; Eggermont et al., 2005) could be explained by the presence of functioning natural killer 
(NK) cells which would attack various immature precursor cells showing low levels of major histocompatibility 
complex expression. The lack of functional NK cells in NOG mouse would then allow the neovascularization of 
human origin to take place. Our experiments clearly demonstrated the presence of functional chimeric human-
mouse vessels with circulating erythrocytes in nude mice as well as in SCID mice, and no major influence of 
hormonal treatment. Our results allow us to suggest that neovascularization of grafts does not seem to be 
dependent on the absence of NK cells. 
Eggermont et al. (2005) demonstrated that revascularization of human endometrial grafts occurred between 5 
and 8 days after implantation into nude mice and was characterized by the disappearance of native human graft 
vessels, coinciding with the invasion of the interface and then the endometrial stroma by murine vessels. In our 
study, by using semithick sections, grafts were fully evaluated, and endometrial stroma was clearly distinguished 
from the fibrotic tissue. We demonstrated the presence of chimeric human-mouse vessels throughout the grafts, 
mouse vessels being observed in the MT surrounding the grafts. We never observed chimeric vessels in fibrotic 
tissue around the grafts. 
Lectins were described as suitable tools for intravital labelling of the vascular system (Debbage et al., 2001). We 
simultaneously perfused mice with two specific lectins which recognized different ligands in the vascular 
endothelial glycocalyx (α-galactose and poly-N-acetyl-lactosamine). By using this technique, we labelled all the 
vessels and therefore followed them in the graft and determined their human and/or mouse origin. At the 
magnification used in Eggermont's study, the exact limit between the endometrial graft stroma and the 
surrounding mouse fibrotic tissue was difficult to assess. Therefore, their results could be explained by a 
progressive time-dependent increase of fibrosis in their endometriotic mouse model which is also observed in 
our nude mice (data not shown). 
Very recently, Mints et al. (2008) showed that bone marrow-derived endothelial progenitors contribute to the 
formation of new blood vessels in the endometrium. They suggested that endometrial angiogenesis develops not 
only from local endothelial cells, but also from  EPCs derived from bone marrow. The presence of mouse vessels 
connected with human vessels in our observations could be explained by the recruitment of mouse EPCs for the 
neovascularization of the endometrial lesions. Further studies are needed to assess this hypothesis. 
In conclusion, by using several markers we observed that human endometrial expiants grafted into two different 
mouse models retained the vessels of human origin. These vessels connected to those of murine origin and 
became functional, as assessed by the presence of erythrocytes in the lumen and by the success of the 
simultaneous perfusion of the two lectins. 
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